Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Elly Barry, Jorge A Alvarez, Rebecca E Scully, Tracie L Miller & Steven E Lipshultz. (2007) Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opinion on Pharmacotherapy 8:8, pages 1039-1058.
Read now
Read now
Varsha Kaushal, G. P. Kaushal & Paulette Mehta. (2004) Differential Toxicity of Anthracyclines on Cultured Endothelial Cells. Endothelium 11:5-6, pages 253-258.
Read now
Read now
Articles from other publishers (19)
Felix Sebastian Nettersheim, Johannes David Schlüter, Wiebke Kreuzberg, Dennis Mehrkens, Simon Grimm, Harshal Nemade, Simon Braumann, Alexander Hof, Henning Guthoff, Vera Peters, Friedrich Felix Hoyer, Yulia Kargapolova, Jan-Wilm Lackmann, Stefan Müller, Christian P. Pallasch, Michael Hallek, Agapios Sachinidis, Matti Adam, Holger Winkels, Stephan Baldus, Simon Geißen & Martin Mollenhauer. (2023) Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy. Basic Research in Cardiology 118:1.
Crossref
Crossref
Paweł Uruski, Julia Matuszewska, Aleksandra Leśniewska, Daniel Rychlewski, Arkadiusz Niklas, Justyna Mikuła-Pietrasik, Andrzej Tykarski & Krzysztof Książek. (2023) An integrative review of nonobvious puzzles of cellular and molecular cardiooncology. Cellular & Molecular Biology Letters 28:1.
Crossref
Crossref
Jie Feng & Yanqing Wu. (2023) Endothelial-to-Mesenchymal Transition: Potential Target of Doxorubicin-Induced Cardiotoxicity. American Journal of Cardiovascular Drugs 23:3, pages 231-246.
Crossref
Crossref
Cho-Won Kim & Kyung-Chul Choi. (2021) Effects of anticancer drugs on the cardiac mitochondrial toxicity and their underlying mechanisms for novel cardiac protective strategies. Life Sciences 277, pages 119607.
Crossref
Crossref
Shengjie Cui, Tushar H. Ganjawala, Gary W. Abrams & Zhuo-Hua Pan. (2020) Effect of Proteasome Inhibitors on the AAV-Mediated Transduction Efficiency in Retinal Bipolar Cells. Current Gene Therapy 19:6, pages 404-412.
Crossref
Crossref
Alessandra Murabito, Emilio Hirsch & Alessandra Ghigo. (2020) Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?. Frontiers in Cardiovascular Medicine 7.
Crossref
Crossref
Sakshi Jasra & Jesus Anampa. (2018) Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review. Current Treatment Options in Oncology 19:6.
Crossref
Crossref
Annie CalvéWilliam NoilesIgal A. SebagLorraine E. Chalifour. (2012) The impact of doxorubicin and dexrazoxane injection of prepubertal female rats on pregnancy outcome and cardiac function postpartum. Canadian Journal of Physiology and Pharmacology 90:11, pages 1527-1534.
Crossref
Crossref
Annie Calvé, Rami Haddad, Sarah-Neiel Barama, Melissa Meilleur, Igal A. Sebag & Lorraine E. Chalifour. (2012) Cardiac response to doxorubicin and dexrazoxane in intact and ovariectomized young female rats at rest and after swim training. American Journal of Physiology-Heart and Circulatory Physiology 302:10, pages H2048-H2057.
Crossref
Crossref
Damian G. Deavall, Elizabeth A. Martin, Judith M. Horner & Ruth Roberts. (2012) Drug-Induced Oxidative Stress and Toxicity. Journal of Toxicology 2012, pages 1-13.
Crossref
Crossref
Yu Yu, Danuta S. Kalinowski, Zaklina Kovacevic, Aritee R. Siafakas, Patric J. Jansson, Christian Stefani, David B. Lovejoy, Philip C. Sharpe, Paul V. Bernhardt & Des R. Richardson. (2009) Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase Inhibitors. Journal of Medicinal Chemistry 52:17, pages 5271-5294.
Crossref
Crossref
O Popelová, M Štěrba, P Hašková, T Šimůnek, M Hroch, I Gunčová, P Nachtigal, M Adamcová, V Geršl & Y Mazurová. (2009) Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death. British Journal of Cancer 101:5, pages 792-802.
Crossref
Crossref
Aarif Y Khakoo & Edward TH Yeh. (2008) Therapy Insight: management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Nature Clinical Practice Oncology 5:11, pages 655-667.
Crossref
Crossref
F Mwale, G Marguier, J.A Ouellet, A Petit, L.M Epure, J Antoniou & L.E Chalifour. (2008) Effect of Dexrazoxane and Amifostine on the Vertebral Bone Quality of Doxorubicin Treated Male Rats. The Open Orthopaedics Journal 2:1, pages 115-120.
Crossref
Crossref
Martin Štěrba, Olga Popelová, Tomáš Šimůnek, Yvona Mazurová, Anna Potáčová, Michaela Adamcová, Ivana Gunčová, Helena Kaiserová, Vladimír Palička, Přemysl Poňka & Vladimír Geršl. (2007) Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH). Toxicology 235:3, pages 150-166.
Crossref
Crossref
Tomáš Šimůnek, Martin Štěrba, Magdaléna Holečková, Jana Kaplanová, Ivona Klimtová, Michaela Adamcová, Vladimír Geršl & Radomír Hrdina. (2005) Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits. BioMetals 18:2, pages 163-169.
Crossref
Crossref
F. Mwale, J. Antoniou, S. Héon, N. Servant, C. Wang, G. M. Kirby, C. N. Demers & L. E. Chalifour. (2004) Gender-Dependent Reductions in Vertebrae Length, Bone Mineral Density and Content by Doxorubicin Are Not Reduced by Dexrazoxane in Young Rats: Effect on Growth Plate and Intervertebral Discs. Calcified Tissue International 76:3, pages 214-221.
Crossref
Crossref
Michael J Mihm, Fushun Yu, David M Weinstein, Peter J Reiser & John Anthony Bauer. (2009) Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase. British Journal of Pharmacology 135:3, pages 581-588.
Crossref
Crossref
Paul Whittaker, Harold E. Seifried, Richard H.C. San, Jane J. Clarke & Virginia C. Dunkel. (2001) Genotoxicity of iron chelators in L5178Y mouse lymphoma cells. Environmental and Molecular Mutagenesis 38:4, pages 347-356.
Crossref
Crossref